Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

ProPhase Labs (PRPH) Dividends payables: 2018

ProPhase Labs' Dividends payables was N/A to $2.9 million in Q4 2018 from the same period last year, while for Dec 2018 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $2.9 million for FY2018, which is N/A change from last year.
ProPhase Labs' Dividends payables amounted to $2.9 million in Q4 2018.
ProPhase Labs' 5-year Dividends payables high stood at $2.9 million for Q4 2018, and its period low was $2.9 million during Q4 2018.
Over the past 1 years, ProPhase Labs' median Dividends payables value was $2.9 million (recorded in 2018), while the average stood at $2.9 million.